Regnante Keith

EDGAR CIK 0001682068

Keros Therapeutics, Inc. - KROS

  1. Manufacturing
  2. Chemicals
  3. Pharmaceutical Preparations
CFO
CHIEF FINANCIAL OFFICER
Direct Buys
0
$0
0 Shares
Direct Sells
1
($77,483)
-4,739 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
02/18/2026
02/20/2026
Sell
-4,739 @ $16.35
 ($77,483) 39,261 (-10.77%) Direct